GST : 27AGPPS8689E1ZF
4.6/5
Our Products
Our Complete range of products are Esomeprazole Magnesium, Erythromycin Powder and Sitagliptin Phosphate.
Esomeprazole is A proton Pump Inhibitor Others Worldwide Which Reduces Stomach Acid secretion Through Inhibition of The h+/k+ atpase in The parietal Cells of the Stomach. By Inhibiting the Functioning of this Transporter, the Drug Prevents Formation of Stomach Acid. It is Used in the Treatment Of dyspepsia, peptic Ulcer Disease, gastroeso- Phageal Reflux Disease, And zollinger-ellison Syndrome. the Primary Uses of Esomeprazole are Treatment and Maintenance Of erosive Esophagitis, Treatment Of duodenal Ulcers caused By h. Pylori, Prevention Of gastric Ulcers in Those On Chronic nsaid therapy, and Treatment of Gastrointestinal Ulcers Associated With crohn's Disease. It Works By Decreasing the Amount of Acid Your Stomach Makes. It Relieves Symptoms such As heartburn, Difficulty Swallowing, and Persistent cough. This medication helps Heal Acid Damage to the Stomach and Esophagus, Helps Prevent Ulcers, and May Help Prevent cancer of the Esophagus.
Details
Erythromycin is a macrolide and macrolide antimicrobial. The physiologic effect of erythromycin is by means of decreased sebaceous gland activity. The chemical classification oferythromycin is macrolides. A bacteriostatic antibiotic macrolide produced by streptomyces erythreus. Erythromycin a is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50s ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erythromycin is a broad-spectrum, macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50s subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
It Is Beta-amino Acid-derived Inhibitor Of Dipeptidyl Peptidase 4 (Ddp-4) With Hypoglycemic Activity. Sitagliptin Phosphate Is A Pyrazine-derived Dipeptidyl-peptidase Iv Inhibitor And Hypoglycemic Agent That Increases The Levels Of The In Cretin Hormones Glucagon-like Peptide-1 (Glp-1) And Glucose-dependent Insulinotropic Polypeptide (Gip). Sitagliptin Is The First In A New Class Of Once Daily, Oral Anti-hyperglycaemic Agents. When Added To Ongoing Metformin Or Pioglitazone Therapy, It Significantly Improved Hba1c In Type-2 Diabetic Patients Who Failed To Achieve Adequate Glycaemic Control With These Agents As Monotherapy And It Was Found To Be Non-inferior To Glipizide When Added To Metformin. This Enzyme-inhibiting Drug Is Used Either Alone Or In Combination With Other Oral Antihyper- Glycemic Agents (Such As Metformin Or A Thiazolidinedione) For Treatment Of Diabetes Mellitus Type 2. The Benefit Of This Medicine Is Its Fewer Side Effects (E.g., Less Hypoglycemia, Less Weight Gain) In The Control Of Blood Glucose Values. While Safety Is Its Advantage, Efficacy Is Often Challenged As It Is Often Recommended To Be Combined With Other Agents Such As Metformin.
Details
Mr. Ashok Shah (UMA Brothers)
C-110, Bhaveshwar Plaza, 189, LBS Marg, Ghatkopar West., Mumbai, Maharashtra - 400086, India
https://www.umabrothers.com
Share us via
